Will resistance in fungi emerge on a scale similar to that seen in bacteria? (Q37060341)

18 August 2017

1 reference

title

Will resistance in fungi emerge on a scale similar to that seen in bacteria? (English)

1 reference

18 August 2017

H Hof

1

1 reference

18 August 2017

19 January 2008

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

18 August 2017

1 reference

18 August 2017

27

1 reference

18 August 2017

327-334

1 reference

18 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-007-0451-9

18 August 2017

0 references

cites work

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0451-9

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0451-9

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0451-9

[Taxonomy and ecology of the genus Candida]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-007-0451-9

A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans

21 January 2018

1 reference

12 December 2020

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

12 December 2020

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

1 reference

12 December 2020

Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.

1 reference

12 December 2020

Hospital-acquired infection surveillance in a neurosurgical intensive care unit.

1 reference

12 December 2020

Resistance of human fungal pathogens to antifungal drugs

1 reference

12 December 2020

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

1 reference

12 December 2020

[Gastrointestinal microecology of humans and Candida]

1 reference

12 December 2020

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

1 reference

12 December 2020

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

1 reference

12 December 2020

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)

1 reference

12 December 2020

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.

1 reference

12 December 2020

Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management

1 reference

12 December 2020

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital

1 reference

12 December 2020

Voriconazole -- better chances for patients with invasive mycoses.

1 reference

12 December 2020

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

1 reference

12 December 2020

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans

1 reference

12 December 2020

Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases

1 reference

12 December 2020

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis

1 reference

12 December 2020

An update on antifungal targets and mechanisms of resistance in Candida albicans

1 reference

12 December 2020

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Antifungal resistance in pathogenic fungi

1 reference

12 December 2020

Development of Fluconazole Resistance inCandida albicansCausing Disseminated Infection in a Patient Undergoing Marrow Transplantation

1 reference

12 December 2020

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

12 December 2020

Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans

1 reference

12 December 2020

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

12 December 2020

Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification

1 reference

12 December 2020

Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates

1 reference

12 December 2020

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Fluconazole resistance mechanisms inCandida krusei: The contribution of efflux-pumps

1 reference

12 December 2020

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

12 December 2020

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance

1 reference

12 December 2020

Population genomics of drug resistance in Candida albicans.

1 reference

12 December 2020

Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

1 reference

12 December 2020

Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans

1 reference

12 December 2020

Invasive oesophageal candidiasis: current and developing treatment options

1 reference

12 December 2020

Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion

1 reference

12 December 2020

Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.

1 reference

12 December 2020

Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.

1 reference

12 December 2020

Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles

1 reference

12 December 2020

Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

12 December 2020

A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.

1 reference

12 December 2020

Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma

1 reference

12 December 2020

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

12 December 2020

Anti-Candida drugs--the biochemical basis for their activity

1 reference

12 December 2020

Biological consequences of petite mutations in Candida glabrata

1 reference

12 December 2020

Critical annotations to the use of azole antifungals for plant protection

1 reference

12 December 2020

Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis

1 reference

12 December 2020

Impact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence

1 reference

12 December 2020

Evolution of antifungal-drug resistance: mechanisms and pathogen fitness

1 reference

12 December 2020

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

12 December 2020

Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital

1 reference

12 December 2020

Multi-azole resistance in Aspergillus fumigatus

1 reference

12 December 2020

International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).

1 reference

12 December 2020

Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

1 reference

12 December 2020

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

12 December 2020

Predicting the emergence of resistance to antifungal drugs.

1 reference

12 December 2020

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

1 reference

12 December 2020

Molecular biological characterization of an azole-resistant Candida glabrata isolate

1 reference

12 December 2020

Mechanisms of azole resistance in petite mutants of Candida glabrata

1 reference

12 December 2020

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

1 reference

12 December 2020

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

1 reference

12 December 2020

Candidaemia in Europe: epidemiology and resistance

1 reference

12 December 2020

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

1 reference

12 December 2020

10.1007/S10096-007-0451-9

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18204870